We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Some Abnormal Breast Lesions May Not Require Surgery

By HospiMedica International staff writers
Posted on 06 Aug 2013
Surgery is not always necessary for women with atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS), abnormalities commonly associated with a higher risk of cancer, according to a new study.

Researchers at Emory University (Atlanta, GA, USA) and the University of Virginia (Charlottesville, USA) studied 10 years of pathology and radiology data to look for a correlation between the number of ALH and LCIS cases that were upgraded to cancer after surgery or follow up, and the concordance between the radiologist and pathologist. More...
The research yielded 50 cases from 49 women aged 40-73 years, with radiologist and pathologist findings were concordant in 43 of the 50 cases.

None of the benign concordant cases were subsequently upgraded to cancer, strongly suggesting that observation in these patients would have been a viable alternative to surgery. Of the seven discordant cases, two were upgraded to ductal carcinoma in situ (DCIS), an early-stage, noninvasive form of breast cancer. The researchers concluded that periodic imaging and clinical examination are effective in these patients when radiology and pathology findings are benign and concordant. The study was published online ahead of print on July 30, 2013, in Radiology.

“When there’s no discordance between the radiologist and pathologist after thorough radiology-pathology correlation, there’s no upgrade from ALH or LCIS to cancer in our study,” said professor of radiology Michael Cohen, MD. “These findings show that some women can avoid surgery, and that yearly mammograms along with MRI or ultrasound as second-line screening tools may suffice.”

ALH occurs in the epithelial cells lining of the milk lobes, producing more cells than would normally grow there. Usually, a lobe is lined with one even layer of uniformly shaped cells, but in lobular hyperplasia there may be several layers of cells. Atypical lobular cells can potentially develop into LCIS, a noninvasive form of breast cancer. Women with ALH or LCIS have a 4 to 10 times higher risk of developing breast cancer.


Related Links:

Emory University

University of Virginia




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.